150 related articles for article (PubMed ID: 31659076)
1. Nanodiscs Incorporating Native β1 Adrenergic Receptor as a Novel Approach for the Detection of Pathological Autoantibodies in Patients with Dilated Cardiomyopathy.
Sun R; Mak S; Haschemi J; Horn P; Boege F; Luppa PB
J Appl Lab Med; 2019 Nov; 4(3):391-403. PubMed ID: 31659076
[TBL] [Abstract][Full Text] [Related]
2. A standardised FACS assay based on native, receptor transfected cells for the clinical diagnosis and monitoring of β1-adrenergic receptor autoantibodies in human heart disease.
Bornholz B; Benninghaus T; Reinke Y; Felix SB; Roggenbuck D; Jahns-Boivin V; Jahns R; Boege F
Clin Chem Lab Med; 2016 Apr; 54(4):683-91. PubMed ID: 26408610
[TBL] [Abstract][Full Text] [Related]
3. Detection of anti-β1-AR autoantibodies in heart failure by a cell-based competition ELISA.
Holthoff HP; Zeibig S; Jahns-Boivin V; Bauer J; Lohse MJ; Kääb S; Clauss S; Jahns R; Schlipp A; Münch G; Ungerer M
Circ Res; 2012 Aug; 111(6):675-84. PubMed ID: 22811559
[TBL] [Abstract][Full Text] [Related]
4. Beta 1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis.
Jane-wit D; Altuntas CZ; Johnson JM; Yong S; Wickley PJ; Clark P; Wang Q; Popović ZB; Penn MS; Damron DS; Perez DM; Tuohy VK
Circulation; 2007 Jul; 116(4):399-410. PubMed ID: 17620508
[TBL] [Abstract][Full Text] [Related]
5. Targeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathy.
Patel PA; Hernandez AF
Eur J Heart Fail; 2013 Jul; 15(7):724-9. PubMed ID: 23639780
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies Specifically Against β1 Adrenergic Receptors and Adverse Clinical Outcome in Patients With Chronic Systolic Heart Failure in the β-Blocker Era: The Importance of Immunoglobulin G3 Subclass.
Nagatomo Y; Li D; Kirsop J; Borowski A; Thakur A; Tang WH
J Card Fail; 2016 Jun; 22(6):417-22. PubMed ID: 26997620
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effect on cardiac function by intravenous immunoglobulin treatment in patients with dilated cardiomyopathy is not due to neutralization of anti-receptor autoantibody.
Larsson L; Mobini R; Aukrust P; Gullestad L; Wallukat G; Waagstein F; Fu M
Autoimmunity; 2004; 37(6-7):489-93. PubMed ID: 15621576
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and therapeutic aspects of β1-adrenergic receptor autoantibodies in human heart disease.
Bornholz B; Roggenbuck D; Jahns R; Boege F
Autoimmun Rev; 2014 Sep; 13(9):954-62. PubMed ID: 25149394
[TBL] [Abstract][Full Text] [Related]
9. Phenotype of early cardiomyopathic changes induced by active immunization of rats with a synthetic peptide corresponding to the second extracellular loop of the human beta-adrenergic receptor.
Buvall L; Bollano E; Chen J; Shultze W; Fu M
Clin Exp Immunol; 2006 Feb; 143(2):209-15. PubMed ID: 16412044
[TBL] [Abstract][Full Text] [Related]
10. [Detection of Autoantibodies Against the 1-Adrenergic Receptor in the Sera of Patients via the Competitive cell-Based Enzyme Linked Immunosorbent Assay].
Shevelev AY; Kostiukevich MV; Efremov EE; Vlasik TN; Mironova NA; Zykov KA; Kashirina NM; Kuznetsova IB; Sharf TV; Mamochkina EN; Lipatova LN; Peklo MM; Rutkevich PN; Yanushevskaya EV; Rybalkin IN; Stukalova OV; Malkina TA; Belyaeva MM; Kuznetsova TV; Tkachev GA; Zinchenko LV; Gupalo EM; Agapova OY; Yureneva-Tkhorzhevskaya TV; Rvacheva AV; Sidorova MV; Sadgyan AS; Tereshchenko SN; Golitsyn SP
Kardiologiia; 2016 Dec; 56(11):61-70. PubMed ID: 28290821
[TBL] [Abstract][Full Text] [Related]
11. Are autoantibodies against the beta1-adrenergic receptor markers for dilated cardiomyopathy?
Arndt-Marić R; Nägele H; Schewe G; Kromminga A
Clin Lab; 2010; 56(11-12):519-26. PubMed ID: 21141435
[TBL] [Abstract][Full Text] [Related]
12. Doberman pinschers present autoimmunity associated with functional autoantibodies: A model to study the autoimmune background of human dilated cardiomyopathy.
Wess G; Wallukat G; Fritscher A; Becker NP; Wenzel K; Müller J; Schimke I
PLoS One; 2019; 14(7):e0214263. PubMed ID: 31276517
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies and Cardiomyopathy: Focus on Beta-1 Adrenergic Receptor Autoantibodies.
Tang WHW; Naga Prasad SV
J Cardiovasc Pharmacol; 2022 Sep; 80(3):354-363. PubMed ID: 35323150
[TBL] [Abstract][Full Text] [Related]
14. Detection of DCM-associated β1-adrenergic receptor autoantibodies requires functional readouts or native human β1-receptors as targets.
Bornholz B; Hanzen B; Reinke Y; Felix SB; Jahns R; Schimke I; Wallukat G; Boege F
Int J Cardiol; 2016 Jan; 202():728-30. PubMed ID: 26461921
[No Abstract] [Full Text] [Related]
15. Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy.
Mobini R; Staudt A; Felix SB; Baumann G; Wallukat G; Deinum J; Svensson H; Hjalmarson A; Fu M
J Autoimmun; 2003 Jun; 20(4):345-50. PubMed ID: 12791320
[TBL] [Abstract][Full Text] [Related]
16. Role of β₁-adrenoceptor autoantibodies in the pathogenesis of dilated cardiomyopathy.
Dandel M; Wallukat G; Potapov E; Hetzer R
Immunobiology; 2012 May; 217(5):511-20. PubMed ID: 21820755
[TBL] [Abstract][Full Text] [Related]
17. [The role of anti-beta1-adrenergic receptor autoantibodies in development of heart failure].
Tonevitskiĭ AG; Tabak'an EA
Ross Fiziol Zh Im I M Sechenova; 2006 Mar; 92(3):330-41. PubMed ID: 16739643
[TBL] [Abstract][Full Text] [Related]
18. A monoclonal antibody directed against an autoimmune epitope on the human beta1-adrenergic receptor recognized in idiopathic dilated cardiomyopathy.
Mobini R; Fu M; Wallukat G; Magnusson Y; Hjalmarson A; Hoebeke J
Hybridoma; 2000 Apr; 19(2):135-42. PubMed ID: 10868793
[TBL] [Abstract][Full Text] [Related]
19. Combined analysis of cross-reacting antibodies anti-β1AR and anti-B13 in advanced stages of Chagas heart disease.
Rodeles LM; Vicco MH; Bontempi IA; Siano A; Tonarelli G; Bottasso OA; Arias P; Marcipar IS
Trop Med Int Health; 2016 Dec; 21(12):1545-1551. PubMed ID: 27699992
[TBL] [Abstract][Full Text] [Related]
20. Anti-calreticulin antibodies and calreticulin in sera of patients diagnosed with dilated or hypertrophic cardiomyopathy.
Sánchez D; Gregor P; Čurila K; Hoffmanová I; Hábová V; Tučková L; Tlaskalová-Hogenová H
Autoimmunity; 2016 Dec; 49(8):554-562. PubMed ID: 27689957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
